Alerta De Seguridad para Premier Buffer A and B Reagent

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Trinity Biotech.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2017-02-28
  • Fecha de publicación del evento
    2017-02-28
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: trinity biotech premier buffer a and b reagent medical device manufacturer, trinity biotech, has issued a medical device safety alert concerning its premier buffer a reagent [product code (lot number): 01-03-0080 (6873, 6669)] and premier buffer b reagent [product code (lot number):: 01-03-0081 (6374), 01-03-0096 (6859, 6639, 6506), 42664 (6528, 6633 and 6526)]. the manufacturer has received reports of difficulty in recovering controls (qc verification), using the above reagent lots, following system activation or standby mode. upon review, the manufacturer has confirmed that the first two test results following system activation or standby mode, with these reagent lots, may result in a low bias, whether they are a control or patient sample. the manufacturer is asking users of the above listed reagent lots for testing to review the following scenarios: if two controls were run directly after activation or standby and met acceptable criteria, there is no action required. if initial controls failed but were re-run and met acceptable criteria, there is no action required. if only patient samples were run directly after activation or standby, then a review of the first two (2) patient sample results is required. affected users should also take the following actions- discontinue the use of the above reagent lots. destroy any remaining product. confirm end-users’ laboratory practice of the use of two controls (qc verification) immediately following system standby and system activations. according to the manufacturer, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 28 february 2017.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Trinity Biotech Premier Buffer A and B Reagent
  • Manufacturer

Manufacturer